Adam Shuttleworth
Survey-based pilot study into the chosen therapy and prophylaxis used by UK primary care veterinary surgeons against canine angiostrongylosis
Shuttleworth, Adam; Dunning, Mark; Wright, Ian; Elsheikha, Hany M.
Authors
Professor MARK DUNNING mark.dunning@nottingham.ac.uk
PROFESSOR
Ian Wright
Professor HANY ELSHEIKHA hany.elsheikha@nottingham.ac.uk
PROFESSOR OF INTERDISCIPLINARY PARASITOLOGY
Abstract
Canine Angiostrongylosis (CA), a gastropod-borne parasitic infection caused by the metastrongyloid nematode Angiostrongylus vasorum, is an important cause of significant morbidity to domestic dogs across the UK as well as in other European countries. This study aimed to ascertain the frequency at which particular drugs were used by primary care practitioners in the UK for therapy against and prophylaxis for CA. Primary care veterinary clinicians were surveyed using an online questionnaire and face-to-face or telephone interviews. Eighty-six veterinary surgeons responded. The majority of practices (n = 52) included lungworm in their standard anthelmintic protocols; moxidectin was the most common drug used for prophylaxis (n = 71). Fenbendazole was the most frequently selected drug, by 45% of vets, for treatment of confirmed cases of CA despite it being unlicensed for this purpose in the UK and the absence of a clear treatment protocol. The results of this pilot study provide an initial insight into the approach taken by primary care practitioners in their approach to CA. This provides an important starting point for future studies investigating the decision-making for CA amongst UK veterinary surgeons, particularly to clarify whether in a larger cohort an unlicensed drug remains the treatment of choice. The absence of a clear protocol for fenbendazole means that treatment of dogs affected by CA may be suboptimal, increasing the risk of morbidity and mortality.
Citation
Shuttleworth, A., Dunning, M., Wright, I., & Elsheikha, H. M. (2018). Survey-based pilot study into the chosen therapy and prophylaxis used by UK primary care veterinary surgeons against canine angiostrongylosis. Veterinary parasitology (Amsterdam), 14, 144-149. https://doi.org/10.1016/j.vprsr.2018.10.010
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 29, 2018 |
Online Publication Date | Oct 30, 2018 |
Publication Date | Dec 21, 2018 |
Deposit Date | Nov 5, 2018 |
Publicly Available Date | Oct 31, 2019 |
Journal | Veterinary Parasitology: Regional Studies and Reports |
Print ISSN | 2405-9390 |
Peer Reviewed | Peer Reviewed |
Volume | 14 |
Pages | 144-149 |
DOI | https://doi.org/10.1016/j.vprsr.2018.10.010 |
Keywords | General Veterinary; Parasitology |
Public URL | https://nottingham-repository.worktribe.com/output/1223418 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S2405939017302691?via%3Dihub |
Contract Date | Nov 5, 2018 |
Files
Survey-based pilot study into the chosen therapy
(9.4 Mb)
PDF
You might also like
Metagenomic profiling of cecal microbiota and antibiotic resistome in rodents
(2024)
Journal Article
Trx4, a novel thioredoxin protein, is important for Toxoplasma gondii fitness
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search